Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Baba

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
CASE (Philadelphia, Pa.)|October 6, 2025
Is This a "True" Apical Sparing Pattern?Yui Yamamoto, Yuri Ochi, Toru Kubo, et al.
Acta Medica Okayama|April 29, 2020
Effects of Switching from Treatment with Amlodipine and Atorvastatin Using Two Pills to an Equal Dose of Single-Pill Therapy in Japanese OutpatientsYasumasa Kawada, Toru Kubo, Yuichi Baba, et al.
Current Drug Targets|June 8, 2018
Pathological Roles of Iron in Cardiovascular DiseaseMotoi Kobayashi, Tomohiro Suhara, Yuichi Baba, et al.
Geriatrics & Gerontology International|November 19, 2016
N-terminal pro-brain natriuretic peptide is a useful marker to identify latent heart failure patients in older adults in a rural outpatient clinicKosuke Hamagawa, Toru Kubo, Kotaro Nishimura, et al.
CASE (Philadelphia, Pa.)|July 1, 2021
A Case Report of Asymmetry of Systolic Anterior Motion of the Mitral Valve, a Not Widely Well-Known but Practically Important Echocardiographic Presentation in Hypertrophic CardiomyopathyYuri Ochi, Toru Kubo, Yuichi Baba, et al.
Molecular Genetics and Metabolism Reports|October 26, 2020
Cardiac manifestations and effects of enzyme replacement therapy for over 10 years in adults with the attenuated form of mucopolysaccharidosis type IKenta Sugiura, Toru Kubo, Yuri Ochi, et al.
Internal Medicine (Tokyo, Japan)|April 13, 2025
Intravenous Verapamil for the Management of Atrial Fibrillation: The Gap Between the Guidelines and Clinical PracticeYuichi Baba, Toru Kubo, Kei Kawada, et al.
Biochemical and Biophysical Research Communications|July 30, 2008
Crystal structure of the covalent intermediate of human cytosolic beta-glucosidaseJunji Noguchi, Yasuhiro Hayashi, Yuichi Baba, et al.
Journal of Cardiology|January 6, 2012
Serum tenascin-C levels as a prognostic biomarker of heart failure events in patients with hypertrophic cardiomyopathyHiroaki Kitaoka, Toru Kubo, Yuichi Baba, et al.
International Heart Journal|January 13, 2017
Prognostic Significance of Non-Dilated Left Ventricular Size and Mitral Regurgitation in Patients With Dilated Phase of Hypertrophic CardiomyopathyToru Kubo, Yuichi Baba, Takayoshi Hirota, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
CASE (Philadelphia, Pa.)|October 6, 2025
Is This a "True" Apical Sparing Pattern?Yui Yamamoto, Yuri Ochi, Toru Kubo, et al.
Acta Medica Okayama|April 29, 2020
Effects of Switching from Treatment with Amlodipine and Atorvastatin Using Two Pills to an Equal Dose of Single-Pill Therapy in Japanese OutpatientsYasumasa Kawada, Toru Kubo, Yuichi Baba, et al.
Current Drug Targets|June 8, 2018
Pathological Roles of Iron in Cardiovascular DiseaseMotoi Kobayashi, Tomohiro Suhara, Yuichi Baba, et al.
Geriatrics & Gerontology International|November 19, 2016
N-terminal pro-brain natriuretic peptide is a useful marker to identify latent heart failure patients in older adults in a rural outpatient clinicKosuke Hamagawa, Toru Kubo, Kotaro Nishimura, et al.
CASE (Philadelphia, Pa.)|July 1, 2021
A Case Report of Asymmetry of Systolic Anterior Motion of the Mitral Valve, a Not Widely Well-Known but Practically Important Echocardiographic Presentation in Hypertrophic CardiomyopathyYuri Ochi, Toru Kubo, Yuichi Baba, et al.
Molecular Genetics and Metabolism Reports|October 26, 2020
Cardiac manifestations and effects of enzyme replacement therapy for over 10 years in adults with the attenuated form of mucopolysaccharidosis type IKenta Sugiura, Toru Kubo, Yuri Ochi, et al.
Internal Medicine (Tokyo, Japan)|April 13, 2025
Intravenous Verapamil for the Management of Atrial Fibrillation: The Gap Between the Guidelines and Clinical PracticeYuichi Baba, Toru Kubo, Kei Kawada, et al.
Biochemical and Biophysical Research Communications|July 30, 2008
Crystal structure of the covalent intermediate of human cytosolic beta-glucosidaseJunji Noguchi, Yasuhiro Hayashi, Yuichi Baba, et al.
Journal of Cardiology|January 6, 2012
Serum tenascin-C levels as a prognostic biomarker of heart failure events in patients with hypertrophic cardiomyopathyHiroaki Kitaoka, Toru Kubo, Yuichi Baba, et al.
International Heart Journal|January 13, 2017
Prognostic Significance of Non-Dilated Left Ventricular Size and Mitral Regurgitation in Patients With Dilated Phase of Hypertrophic CardiomyopathyToru Kubo, Yuichi Baba, Takayoshi Hirota, et al.
Pageof 11